[144] Dolby Laboratories, Inc. SEC Filing
Dolby Laboratories (DLB) Form 144 shows a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney on 08/12/2025 with an aggregate market value of $1,807,827.50. The filing lists 95,844,185 shares outstanding, and the securities were acquired the same day by stock option exercise with payment in cash. The notice also records multiple recent sales by Yeaman Family Trust between 06/10/2025 and 07/16/2025 in several tranches. By signing, the seller represents they are not aware of any undisclosed material adverse information; a Rule 10b5-1 plan date is not indicated.
Dolby Laboratories (DLB) Il Modulo 144 indica una proposta di vendita di 25,000 azioni ordinarie tramite Morgan Stanley Smith Barney in data 08/12/2025, per un valore di mercato complessivo di $1,807,827.50. La comunicazione riporta 95,844,185 azioni in circolazione; i titoli sono stati acquisiti lo stesso giorno mediante esercizio di opzioni su azioni con pagamento in contanti. L'avviso registra inoltre più vendite recenti da parte del Yeaman Family Trust tra il 06/10/2025 e il 07/16/2025 in più tranche. Firmando, il venditore dichiara di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate; non è indicata la data di un piano ai sensi della Rule 10b5-1.
Dolby Laboratories (DLB) El Formulario 144 muestra una propuesta de venta de 25,000 acciones ordinarias a través de Morgan Stanley Smith Barney con fecha 08/12/2025 por un valor de mercado total de $1,807,827.50. La presentación indica 95,844,185 acciones en circulación; los valores fueron adquiridos el mismo día mediante ejercicio de opciones sobre acciones con pago en efectivo. El aviso también registra varias ventas recientes del Yeaman Family Trust entre el 06/10/2025 y el 07/16/2025 en varios tramos. Al firmar, el vendedor declara no tener conocimiento de información material adversa no divulgada; no se indica la fecha de un plan conforme a la Rule 10b5-1.
Dolby Laboratories (DLB) Form 144 서류는 Morgan Stanley Smith Barney를 통해 08/12/2025에 25,000 보통주 매도를 제안했으며, 총 시가가 $1,807,827.50로 기재되어 있습니다. 제출서에는 95,844,185 주의 발행 주식 수가 기재되어 있고, 해당 증권은 같은 날 스톡옵션 행사로 취득되었으며 대금은 현금으로 지급되었습니다. 통지서에는 또한 06/10/2025과 07/16/2025 사이에 Yeaman Family Trust가 여러 차례에 걸쳐 최근 판매를 한 기록도 포함되어 있습니다. 서명으로 판매자는 공개되지 않은 중대한 불리한 정보가 없음을 진술하며, Rule 10b5-1 계획의 날짜는 표시되어 있지 않습니다.
Dolby Laboratories (DLB) Le formulaire 144 indique une proposition de vente de 25,000 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney le 08/12/2025, pour une valeur marchande totale de $1,807,827.50. Le dépôt mentionne 95,844,185 actions en circulation ; les titres ont été acquis le même jour par exercice d'options sur actions avec paiement en espèces. L'avis relève également plusieurs ventes récentes du Yeaman Family Trust entre le 06/10/2025 et le 07/16/2025 en plusieurs tranches. En signant, le vendeur déclare ne pas être au courant d'informations défavorables importantes non divulguées ; la date d'un plan au titre de la Rule 10b5-1 n'est pas indiquée.
Dolby Laboratories (DLB) Das Formular 144 zeigt einen vorgeschlagenen Verkauf von 25,000 Stammaktien über Morgan Stanley Smith Barney am 08/12/2025 mit einem Gesamtmarktwert von $1,807,827.50. Die Meldung gibt 95,844,185 ausstehende Aktien an; die Wertpapiere wurden am selben Tag durch Ausübung von Aktienoptionen erworben und mit Bargeld bezahlt. Die Mitteilung verzeichnet außerdem mehrere jüngste Verkäufe des Yeaman Family Trust zwischen 06/10/2025 und 07/16/2025 in mehreren Tranchen. Durch seine Unterschrift erklärt der Verkäufer, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind; ein Datum für einen Plan nach der Rule 10b5-1 ist nicht angegeben.
- None.
- None.
Insights
TL;DR Insider/related-party sales are noted but the proposed 25,000-share sale is small versus total outstanding shares.
The filing discloses a planned sale of 25,000 shares valued at $1.81M executed through Morgan Stanley on 08/12/2025 and securities acquired that same day via stock option exercise paid in cash. The company’s outstanding share count is reported as 95,844,185, making the single proposed transaction a very small fraction of total equity. Multiple prior sales by Yeaman Family Trust across June–July 2025 are recorded, indicating ongoing disposition activity by that account. From a financial-materiality perspective, these volumes are unlikely to move valuation but are relevant for share supply monitoring and insider activity transparency.
TL;DR The notice is a routine Rule 144 disclosure; it includes the standard insider representation about material nonpublic information.
The Form 144 contains expected elements: broker details (Morgan Stanley Smith Barney), acquisition method (stock option exercise), payment in cash, and a signed representation that the seller does not possess undisclosed material adverse information. There is mention of Rule 10b5-1 but no plan adoption date is provided on the form. Governance-wise, the filing meets disclosure requirements by listing recent related sales and the proposed sale, supporting market transparency without revealing additional governance concerns.
Dolby Laboratories (DLB) Il Modulo 144 indica una proposta di vendita di 25,000 azioni ordinarie tramite Morgan Stanley Smith Barney in data 08/12/2025, per un valore di mercato complessivo di $1,807,827.50. La comunicazione riporta 95,844,185 azioni in circolazione; i titoli sono stati acquisiti lo stesso giorno mediante esercizio di opzioni su azioni con pagamento in contanti. L'avviso registra inoltre più vendite recenti da parte del Yeaman Family Trust tra il 06/10/2025 e il 07/16/2025 in più tranche. Firmando, il venditore dichiara di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate; non è indicata la data di un piano ai sensi della Rule 10b5-1.
Dolby Laboratories (DLB) El Formulario 144 muestra una propuesta de venta de 25,000 acciones ordinarias a través de Morgan Stanley Smith Barney con fecha 08/12/2025 por un valor de mercado total de $1,807,827.50. La presentación indica 95,844,185 acciones en circulación; los valores fueron adquiridos el mismo día mediante ejercicio de opciones sobre acciones con pago en efectivo. El aviso también registra varias ventas recientes del Yeaman Family Trust entre el 06/10/2025 y el 07/16/2025 en varios tramos. Al firmar, el vendedor declara no tener conocimiento de información material adversa no divulgada; no se indica la fecha de un plan conforme a la Rule 10b5-1.
Dolby Laboratories (DLB) Form 144 서류는 Morgan Stanley Smith Barney를 통해 08/12/2025에 25,000 보통주 매도를 제안했으며, 총 시가가 $1,807,827.50로 기재되어 있습니다. 제출서에는 95,844,185 주의 발행 주식 수가 기재되어 있고, 해당 증권은 같은 날 스톡옵션 행사로 취득되었으며 대금은 현금으로 지급되었습니다. 통지서에는 또한 06/10/2025과 07/16/2025 사이에 Yeaman Family Trust가 여러 차례에 걸쳐 최근 판매를 한 기록도 포함되어 있습니다. 서명으로 판매자는 공개되지 않은 중대한 불리한 정보가 없음을 진술하며, Rule 10b5-1 계획의 날짜는 표시되어 있지 않습니다.
Dolby Laboratories (DLB) Le formulaire 144 indique une proposition de vente de 25,000 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney le 08/12/2025, pour une valeur marchande totale de $1,807,827.50. Le dépôt mentionne 95,844,185 actions en circulation ; les titres ont été acquis le même jour par exercice d'options sur actions avec paiement en espèces. L'avis relève également plusieurs ventes récentes du Yeaman Family Trust entre le 06/10/2025 et le 07/16/2025 en plusieurs tranches. En signant, le vendeur déclare ne pas être au courant d'informations défavorables importantes non divulguées ; la date d'un plan au titre de la Rule 10b5-1 n'est pas indiquée.
Dolby Laboratories (DLB) Das Formular 144 zeigt einen vorgeschlagenen Verkauf von 25,000 Stammaktien über Morgan Stanley Smith Barney am 08/12/2025 mit einem Gesamtmarktwert von $1,807,827.50. Die Meldung gibt 95,844,185 ausstehende Aktien an; die Wertpapiere wurden am selben Tag durch Ausübung von Aktienoptionen erworben und mit Bargeld bezahlt. Die Mitteilung verzeichnet außerdem mehrere jüngste Verkäufe des Yeaman Family Trust zwischen 06/10/2025 und 07/16/2025 in mehreren Tranchen. Durch seine Unterschrift erklärt der Verkäufer, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind; ein Datum für einen Plan nach der Rule 10b5-1 ist nicht angegeben.
FAQ
What shares does the DLB Form 144 propose to sell?
How were the securities acquired for the proposed sale in the DLB filing?
What recent sales by related parties are disclosed in the Form 144?
Does the filer state they possess any material nonpublic information?
Is a Rule 10b5-1 trading plan date provided in the DLB Form 144?
